CELEBRITY CRUISES LAUNCHES ‘DREAM MAKERS,’ A FIRST OF ITS KIND INVITATION FOR TRAVELERS TO DREAM UP THEIR PERFECT VACATION ON CELEBRITY XCEL

In an industry first, cruisers will help make key decisions across culinary, entertainment and interior design to finalize Celebrity Xcel, the cruise line's newest billion-dollar ship. Celebrity Cruises is inviting vacationers worldwide to create their dream vacation experience onCelebrity Xcel®with Xcel 'Dream MakersSM.' Open to all who wish to join, this global community will test, […]

Top Priorities for Cybersecurity Leaders in 2025: Info-Tech Research Group Publishes Annual Report

Info-Tech Research Group, a global leader in IT research and advisory, has published its Security Priorities 2025 report, providing essential guidance to cybersecurity leaders as they navigate an increasingly complex threat landscape. The report highlights actionable strategies to operationalize AI security, strengthen identity management programs, and prepare for the challenges posed by quantum computing and

ACTG Launches Second HIV Cure Clinical Trial in Africa

LOS ANGELES, Jan. 21, 2025 (GLOBE NEWSWIRE) — ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of the ACACIA study (Antiretrovirals Combined with Antibodies for HIV-1 Cure in Africa), also known as A5417. ACACIA is a phase 2, double-blind, randomized study evaluating the safety and virologic

/C O R R E C T I O N — Lummus Technology, LLC/

In the news release, Lummus Expands Portfolio through Versalis Partnership, issued 21-Jan-2025 by Lummus Technology, LLC over PR Newswire, the dateline location should read “HOUSTON and SAN DONATO MILANESE, Italy” rather than “HOUSTON and SAN DONATO MILANESE, Mich.” as incorrectly transmitted by PR Newswire. The complete, corrected release follows: Lummus Expands Portfolio through Versalis Partnership

Hankook Tire Launches New Dynapro and Ventus Tires

All-New Dynapro evo AS provides ultimate all-season performance for SUVs- Second-generation Dynapro HT2 optimized for year-round comfort and durability with 70K mileage warranty- Ventusevo and Ventus evo SUV summer tires developed for unmatched sports driving experience Leading global tiremaker Hankook Tire today announced two new products for its Dynapro SUV and light truck portfolio as

Richard Childress Racing and Rebel Bourbon Revved Up to Roll

Rebel Bourbon continues sponsorship of Richard Childress Racing and driver Kyle Busch for 2025 NASCAR Cup Series season Bardstown, Kentucky-based Rebel® Bourbon kicks off 2025 as the Official Bourbon of Richard Childress Racing, the No. 8 Chevrolet, and two-time NASCAR Cup Series Champion Kyle Busch. Following a successful first year in 2024, Rebel Bourbon once

Polaris is Offering Free Snowmobile Rides this Winter

Polaris invites people to experience an adventure in the snow with a free snowmobile ride at a Polaris Adventures Outfitter location of their choice Polaris Inc. (NYSE:PII), the global leader in powersports, today announced it is offering free snowmobile rides at more than 50 participating Polaris Adventures Outfitter locations across the country. This program builds

Singular Genomics Systems, Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Shareholders To Reach Out

LOS ANGELES, CA / ACCESS Newswire / January 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Singular Genomics Systems, Inc. ("Singular Genomics" or "the Company") (NASDAQ:OMIC) for potential breaches of fiduciary duty on the part of its directors and

Investors in Regeneron Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights – REGN

NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=124114&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of MGP Ingredients, Inc. (MGPI) Shareholders

NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your MGP Ingredients, Inc. (NASDAQ:MGPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/mgp-ingredients-inc-lawsuit-submission-form?prid=124113&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Scroll to Top